about
The crystal structure of Toxoplasma gondii pyruvate kinase 1Cancer as a metabolic diseaseTyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolismC6ORF66 is an assembly factor of mitochondrial complex IModulation of M2-type pyruvate kinase activity by the cytoplasmic PML tumor suppressor proteinThe glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferationTargeting cellular metabolism to improve cancer therapeuticsMicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cellsInhibition of alanine aminotransferase in silico and in vivo promotes mitochondrial metabolism to impair malignant growthHypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation.Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancerBrick by brick: metabolism and tumor cell growthHypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1Insights into the Regulatory Role of Non-coding RNAs in Cancer MetabolismAnticancer strategies based on the metabolic profile of tumor cells: therapeutic targeting of the Warburg effectHypoxia-inducible factors as molecular targets for liver diseasesGenome management and mismanagement--cell-level opportunities and challenges of whole-genome duplicationCancer Metabolism and Drug ResistanceCaveolin-1, a stress-related oncotarget, in drug resistanceOvarian clear cell carcinoma meets metabolism; HNF-1β confers survival benefits through the Warburg effect and ROS reductionThe links between insulin resistance, diabetes, and cancerHypoxamiRs and cancer: from biology to targeted therapyThe potential of ¹¹C-acetate PET for monitoring the Fatty acid synthesis pathway in TumorsPleiotropic role of HSF1 in neoplastic transformationCell cycle regulators guide mitochondrial activity in radiation-induced adaptive responseOrganelle targeting: third level of drug targetingKRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism.Ligand-based targeted therapy: a novel strategy for hepatocellular carcinomaTumor Microenvironment Metabolism: A New Checkpoint for Anti-Tumor ImmunityClinical photoacoustic imaging of cancerHypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symportersInfection homeostasis: implications for therapeutic and immune programming of metabolism in controlling infectionDysfunctional mitochondrial bioenergetics and the pathogenesis of hepatic disordersFeeding an army: The metabolism of T cells in activation, anergy, and exhaustionEnzymatic methods for glyco(diversification/randomization) of drugs and small moleculesA phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumorsMetabolic modulation of glioblastoma with dichloroacetateInterpreting expression data with metabolic flux models: predicting Mycobacterium tuberculosis mycolic acid productionSystems-scale analysis reveals pathways involved in cellular response to methamphetamineClotrimazole preferentially inhibits human breast cancer cell proliferation, viability and glycolysis
P2860
Q21136151-C892E705-DC98-41E0-AB12-FC86ACA71A70Q21245061-34064F78-757B-47BF-B001-48F6EA272237Q24300524-22BEDB86-27F0-41D1-BB9B-37D2FE70836AQ24305552-F3C508B0-B7A0-42ED-ADD6-5091EB3FF10EQ24317314-97DCC841-779A-41F1-88D6-5C3FF92CDE29Q24336894-1A0E1A55-4814-46BC-B953-7D0E892CE852Q24596727-9AE0CE6A-67DD-428A-ABCD-7F69575CBAE0Q24603505-FEBCE783-ECF8-4D9E-A138-BA55BF847F28Q24608319-FB5794E6-FCA0-42B9-BEA7-DB55675B71F8Q24651016-6B4D36D0-87A6-4EE1-BD87-71DDCF55AAC8Q24652941-7E9329E2-C564-421B-8045-867140A8F412Q24656187-7DDC9208-DE64-4E6E-99F9-28C908E043EBQ24681460-1CCEAF06-AFB4-49F2-872F-1B459327A209Q26739857-3DF7D424-66CC-426B-B988-65B5FA3B0AEEQ26745461-3C79B218-32E2-4A83-BB81-8B7247F6B663Q26752304-92B522E9-EA8B-4C11-9A87-32694EF9D3E3Q26774293-88C59EE6-9823-4C66-886B-C18861AEF58AQ26782042-371E6148-3602-4571-A210-75897E2CA6DAQ26782615-E9FE2032-E875-4442-9863-ED49F950E986Q26786610-2A0BB079-B13F-4C18-B5B9-7C85CD642EA1Q26852910-048F9FBE-CFB7-4888-B3EB-D483ED858265Q26863298-B2EF1479-D2BD-44B6-9990-F73C31FD6AF8Q26996477-53B99201-B62B-4464-B666-BB4A5CA7C3D7Q27010679-5B2E8A6E-6132-47ED-9913-03AAE0DCAD1FQ27014767-5577652B-FB8C-481B-BA72-CF666DB45F71Q27014902-B5FE9D72-4C76-4EA9-AEAF-4B432B69C454Q27853300-F3800CF9-4CC3-4929-8096-A57C8F93067BQ28068437-CCBD8F01-78D9-41F7-8B7F-773A66B5C881Q28077647-C08068A0-4A0C-4B82-88A9-BA3177879D52Q28078790-13D3DAF6-A158-47F7-B904-5E6FC0D65BA5Q28081811-403143F2-68B2-45DA-8D3C-48B9D7DA8B5EQ28083186-1FE37E5D-1453-4E04-804C-42F1C843B2FBQ28083336-A75FED54-8D2E-4E79-AF40-99A2006151C8Q28085624-DE138759-1F74-406A-BC75-493D5EBB4478Q28247479-32F34E2F-B522-4614-90E5-368483BB682DQ28281237-505FAF9E-CADB-4239-ACAE-63641485010EQ28282255-AD0F479E-26B1-48FE-BACC-EDB788036662Q28475985-F4C678D4-51E8-418A-9F41-4AE705847A7FQ28477826-F12374FD-0F25-4AD8-846B-63B0FC4E3B1CQ28480562-52C59D04-1BB0-4D46-A028-39963D8B85AB
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Cancer's molecular sweet tooth and the Warburg effect.
@ast
Cancer's molecular sweet tooth and the Warburg effect.
@en
Cancer's molecular sweet tooth and the Warburg effect.
@nl
type
label
Cancer's molecular sweet tooth and the Warburg effect.
@ast
Cancer's molecular sweet tooth and the Warburg effect.
@en
Cancer's molecular sweet tooth and the Warburg effect.
@nl
prefLabel
Cancer's molecular sweet tooth and the Warburg effect.
@ast
Cancer's molecular sweet tooth and the Warburg effect.
@en
Cancer's molecular sweet tooth and the Warburg effect.
@nl
P1433
P1476
Cancer's molecular sweet tooth and the Warburg effect
@en
P2093
Chi V Dang
Jung-whan Kim
P304
P356
10.1158/0008-5472.CAN-06-1501
P407
P577
2006-09-01T00:00:00Z